Pictet Asset Management (Switzerland)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$33.8M Buy
943,019
+553,538
+142% +$15.9M 0.04% 354
2023
Q1
$9.13M Sell
389,481
-219,499
-36% -$6.27M 0.01% 636
2022
Q4
$16.6M Sell
608,980
-73,977
-11% -$3.39M 0.02% 483
2022
Q3
$36.8M Sell
682,957
-351,695
-34% -$18.1M 0.05% 321
2022
Q2
$41.7M Buy
1,034,652
+697,281
+207% +$34.5M 0.06% 314
2022
Q1
$22.3M Buy
337,371
+8,755
+3% +$599K 0.03% 473
2021
Q4
$32.9M Sell
328,616
-164,160
-33% -$17M 0.03% 421
2021
Q3
$61.6M Buy
+492,776
New +$58.5M 0.07% 299

Other funds holding GH

Pictet Asset Management (Switzerland)'s GH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Guardant Health (GH) stake by 142% in Q2 2023, buying an estimated $15.9M and bringing the position to 943,019 shares worth $33.8M. The position accounts for 0.04% of the portfolio, ranked #354.

Pictet Asset Management (Switzerland) first reported a position in GH in Q3 2021 and has held it in 8 quarters since. The position peaked at $61.6M in Q3 2021. 301 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 943,019 shares of Guardant Health worth $33.8M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 553,538 Guardant Health shares in Q2 2023, an estimated $15.9M.
  • Guardant Health made up 0.04% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #354 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Guardant Health in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Guardant Health position peaked at $61.6M in Q3 2021.
  • 301 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.